BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 3275777)

  • 1. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
    Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA
    J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
    TenBrink RE; Pals DT; Harris DW; Johnson GA
    J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-conformation relationships of synthetic peptide inhibitors of human renin studied by resonance energy transfer and molecular modeling.
    Epps DE; Mao B; Staples DJ; Sawyer TK
    Int J Pept Protein Res; 1988 Jan; 31(1):22-34. PubMed ID: 3284834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
    Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
    J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New renin inhibitors containing novel analogues of statine.
    Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
    J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate specificity of porcine renin: P1', P1, and P3 residues of renin substrates are crucial for activity.
    Wang W; Liang TC
    Biochemistry; 1994 Dec; 33(48):14636-41. PubMed ID: 7981226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of potent gastrin-releasing peptide antagonists having a D-Pro-psi(CH2NH)-Phe-NH2 C terminus.
    Leban JJ; Kull FC; Landavazo A; Stockstill B; McDermed JD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1922-6. PubMed ID: 8446610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogs.
    Sawyer TK; Staples DJ; Liu L; Tomasselli AG; Hui JO; O'Connell K; Schostarez H; Hester JB; Moon J; Howe WJ
    Int J Pept Protein Res; 1992; 40(3-4):274-81. PubMed ID: 1478785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of rat renin inhibitory peptides.
    Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E
    J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
    Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
    J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
    Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
    J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
    Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
    J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Etoh Y; Shimaoka I; Tsubaki A; Murakami M; Yamaguchi T
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2487-93. PubMed ID: 2285979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psi [CH2NH] backbone-modified peptides: first unequivocal observation of a C7 structure in a linear peptide.
    Toniolo C; Valle G; Crisma M; Kaltenbronn JS; Repine JT; Van Binst G; Elseviers M; Tourwé D
    Pept Res; 1989; 2(5):332-7. PubMed ID: 2520771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inhibitors of human renin. Cyclic peptides based on the tetrapeptide sequence Glu-D-Phe-Lys-D-Trp.
    Dutta AS; Gormley JJ; McLachlan PF; Major JS
    J Med Chem; 1990 Sep; 33(9):2552-60. PubMed ID: 2202828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray analysis at 2.0 A resolution of mouse submaxillary renin complexed with a decapeptide inhibitor CH-66, based on the 4-16 fragment of rat angiotensinogen.
    Dealwis CG; Frazao C; Badasso M; Cooper JB; Tickle IJ; Driessen H; Blundell TL; Murakami K; Miyazaki H; Sueiras-Diaz J
    J Mol Biol; 1994 Feb; 236(1):342-60. PubMed ID: 8107115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of potent, low molecular weight renin inhibitors.
    Sueiras-Diaz J; Jones DM; Szelke M; Deinum J; Svensson L; Westerlund C; Sohtell M
    J Pept Res; 1997 Oct; 50(4):248-61. PubMed ID: 9352463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
    J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.